Home › Sistema immunitario e disturbi › Pennsylvania › Philadelphia
Studi clinici su Sistema immunitario e disturbi a Philadelphia, PA
10 studi su Sistema immunitario e disturbi cercano partecipanti presso sedi a Philadelphia e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
In reclutamentoFase 1
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
In reclutamentoFase 3
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
In reclutamentoStudio osservazionale
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · a 23 mi di distanza
- Christiana Care Health System-Wilmington Hospital, Wilmington · a 25 mi di distanza
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
In reclutamentoFase 3
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
In reclutamentoFase 1/2
- Thomas Jefferson University, Philadelphia
Abatacept for the Treatment of Giant Cell Arteritis
In reclutamentoFase 3
- University of Pennsylvania, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
In reclutamentoFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
In reclutamentoFase 2
- Children's Hospital of Philadelphia, Philadelphia
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
In reclutamentoFase 1/2
- Nemours Children's Health, Wilmington · a 25 mi di distanza
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
In reclutamentoFase 1/2
- University of Pennsylvania, Philadelphia
Studi su Sistema immunitario e disturbi in altre città
- Washington, DC13 studi
- New York City, NY12 studi
- Boston, MA10 studi
- Portland, OR9 studi
- Atlanta, GA9 studi
- Houston, TX9 studi
- Chicago, IL8 studi
- Los Angeles, CA8 studi
- Cleveland, OH8 studi
- Seattle, WA6 studi
- Milwaukee, WI6 studi
- Cedar Rapids, IA6 studi
Altri studi a Philadelphia
- Cancro (tutti i tipi)59 studi
- Cancro al seno56 studi
- Cancro del polmone non a piccole cellule51 studi
- Cancro metastatico46 studi
- Cancro colorettale44 studi
- Cancro ovarico44 studi
- Cancro alla prostata44 studi
- Cancro ai polmoni36 studi
- Leucemia mieloide acuta34 studi
- Insufficienza cardiaca31 studi
- Cancro dell'endometrio28 studi
- Depressione26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.